Oral question asked in the House of Commons, by John Leech (Liberal Democrat). It was answered by Jane Kennedy (Labour) on Tuesday, 7 March 2006 on behalf of the Department of Health.
Colorants
- Question
- What assessment she has made of the level of use of colorants in the manufacture of medicines; and if she will make a statement. [56292]
- Answer
-
The addition of small levels of colorants to medicines can often be justified as a way of identifying and distinguishing the different types and strengths of a medicine. That can be very important to patients taking several medicines, for example. However, the use of any substance in a medicine, as well as the drug itself, must be justified under EU legislation before it is granted a marketing authorisation.
Secondary information
- Type
- Oral question
- Reference
- 443 c707
- 56292
- Session
- 2005-06
- Oral question type
- Lead
- Chamber / Committee
- House of Commons chamber
- Related items
- Subjects
- Additives Colourings Licensing EU law Drugs Prescription drugs Levels
- Link
- View this Oral question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-04-12 03:23:29 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1118787
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1118787
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1118787